Drug Type AAV based gene therapy |
Synonyms SG 001, SG-001, SG001 + [2] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Phase 1 | CN | 16 Oct 2024 | |
Amyotrophic Lateral Sclerosis | Phase 1 | CN | 16 Oct 2024 | |
Alzheimer Disease | Preclinical | CN | 25 Mar 2024 | |
Stroke | Preclinical | CN | 25 Mar 2024 |